Xingnaojing for Moderate-to-severe Acute ischemic Stroke (XMAS): study protocol for a randomized controlled trial
作者: Xinxing LaiKegang CaoLingbo KongQiang LiuYing Gaofor the XMAS study investigators
作者单位: 1Dongzhimen Hospital affiliated to Beijing University of Chinese Medicine
2Institute for Cerebrovascular Disease of Beijing University of Chinese Medicine
3the Word Federation of Chinese Medicine Societies
刊名: Trials, 2017, Vol.18 (1)
来源数据库: Springer Nature Journal
DOI: 10.1186/s13063-017-2222-y
关键词: Xingnaojing injectionChinese medicineAcute ischemic strokeRandomized controlled trial
英文摘要: Xingnaojing injection (XNJ) is widely used for the treatment of stroke in China. However, there is currently a lack of high-quality evidence of its efficacy for acute ischemic stroke. The main objective of this study is to determine whether the addition of XNJ to standard care improves the 3-month functional outcome in patients with acute ischemic stroke (AIS).
原始语种摘要: Xingnaojing injection (XNJ) is widely used for the treatment of stroke in China. However, there is currently a lack of high-quality evidence of its efficacy for acute ischemic stroke. The main objective of this study is to determine whether the addition of XNJ to standard care improves the 3-month functional outcome in patients with acute ischemic stroke (AIS).
全文获取路径: Springer Nature  (合作)
分享到:
来源刊物:
影响因子:2.206 (2012)

×
关键词翻译
关键词翻译
  • ischemic 福尔克曼氏麻痹
  • controlled 受控
  • stroke 笔划
  • trial 试验
  • injection 贯入
  • objective 接物镜
  • protocol 日态
  • functional 功能的
  • whether 是否
  • severe 严滥